A study to assess the ability of the HFA-ICOS risk stratification tool to predict cancer therapy-related cardiac dysfunction for patients receiving anthracycline chemotherapy.

Back

ESC2024 Premium Access

A study to assess the ability of the HFA-ICOS risk stratification tool to predict cancer therapy-related cardiac dysfunction for patients receiving anthracycline chemotherapy.

Session: Cardiovascular complications in cardio-oncology: risk assessment

Topic: Cardio-Oncology

Speaker: Doctor A. Byrne (Godalming, GB)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Alex Byrne

Godalming (United Kingdom of Great Britain & Northern Ireland)

0 follower

8 more presentations in this session

The prognostic significance of Weber and ventilatory CPET classifications in amyloidosis patients

Speaker: Doctor S. Santos Patarroyo (Rochester, US) Doctor L. Ortega Aviles (Rochester, US)

Assessment of poor cardiovascular health metrics and related disparities among cancer patients in the United States: a nationwide analysis of over 1.5 million individuals

Speaker: Doctor S. Abohashem (Boston, US)

Cardiovascular effects of BRAF and MEK inhibitors in patients with melanoma: a prospective study incorporating risk scores, cardiac biomarkers and cardiovascular magnetic resonance imaging

Speaker: Doctor C. Glen (Glasgow, GB)

Role of liraglutide on cardiotoxicity and gut microbiota changes induced by doxorubicin in rats

Speaker: Doctor C. Rodrigues Tonon (Botucatu, BR)

Real-world analysis of transcatheter aortic valve replacement in patients with prostate cancer and severe aortic stenosis

Speaker: Doctor R. Belo Nunes (Sao Paulo, BR)

Access the full session

Cardiovascular complications in cardio-oncology: risk assessment

Speakers: Doctor A. Byrne, Doctor S. Santos Patarroyo, Doctor L. Ortega Aviles, Doctor S. Abohashem, Doctor C. Glen...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources